Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Recenti Progressi in Medicina|December 15, 2025
[Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.]Lorenzo Belluomini, Sara Pilotto
Oncology and Therapy|July 24, 2020
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a FlukeLorenzo Belluomini, Francesco Fiorica, Antonio Frassoldati
Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.
Expert Opinion on Biological Therapy|March 30, 2023
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancerLorenzo Belluomini, Alice Avancini, Marco Sposito, et al.
Critical Reviews in Oncology/Hematology|January 19, 2025
Real-world evidence in extensive disease small cell lung cancer: The missing piece of the puzzlePaola Damiano, Alessio Stefani, Alice Avancini, et al.
Expert Review of Hematology|November 17, 2021
Exercise and anemia in cancer patients: could it make the difference?Alice Avancini, Lorenzo Belluomini, Daniela Tregnago, et al.
Expert Opinion on Biological Therapy|September 23, 2024
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agentsMarco Sposito, Serena Eccher, Ilaria Scaglione, et al.
Critical Reviews in Oncology/Hematology|October 22, 2019
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapyStefania Gori, Alessandro Inno, Lorenzo Belluomini, et al.
Cancers|November 25, 2023
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody-Drug ConjugatesLorenzo Belluomini, Marco Sposito, Alice Avancini, et al.
American Journal of Clinical Oncology|February 2, 2018
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of CombinationFrancesco Fiorica, Lorenzo Belluomini, Antonio Stefanelli, et al.
Pageof 10